£315k
+28%vs Mar 2025Active12418793Private limited companyMorden
ONCOTECHNOLOGIES LTD
Significant control: Matthew Hardy Williams (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Oncotechnologies Ltd sell?
Registered activity: Specialists medical practice activities (SIC 86220). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
ONCOTECHNOLOGIES LTD is an active private limited company (company number 12418793) incorporated on 22 January 2020, registered in Morden. Its registered activity is specialists medical practice activities (SIC 86220). Latest micro accounts cover the period ending 31 March 2026, showing net assets of £315k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 28% on the prior period (£246k). Across the last 3 periods on record the net-asset trend is rising.
Peer position · net assets
By net assets it sits in the top quarter of 1,823 comparable companies in Greater London (median £18k, upper quartile £117k).
02
Ownership and control
- Mr Matthew Hardy Williams
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 22 January 20206 yrs ago
- Next accounts due
- 31 December 2027in 434 days
- Confirmation statement due
- 5 February 2027in 105 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 86220
- Specialists medical practice activities
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
2
No changevs Mar 2025| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2026 | £315k | — | — | £56k | — | — | 2 |
| 31 March 2025 | £246k | — | — | £18k | — | — | 2 |
| 31 March 2024 | £240k | — | — | £25k | — | — | 2 |
Current ratio6.62Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £315,130 at 31 March 2026
- Net assets up 10% or more on the prior period+28.2% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 6.62
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 22 January 2020
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 434 days
- Confirmation statement duein 105 days
- Accounts period endNet assets £315k · micro accounts
- Accounts period endNet assets £246k · micro accounts
- Accounts period endNet assets £240k · micro accounts
- Incorporated
08
Similar companies in Greater London
- KONCEPT MEDICAL CLINIC LIMITEDKingston Upon Thames · inc. Jan 2020
- LONDON HEART INVESTIGATIONS LIMITEDHarrow · inc. Jan 2020
- INTERNATIONAL HEART CLINIC LTDUpminster · inc. Jan 2020
- PRESTIGE RADIOLOGY LIMITEDIlford · inc. Jan 2020
- DERMELLE LIMITEDEpsom · inc. Jan 2020
- PURE RHEUMATOLOGY LONDON LTDWaltham Cross · inc. Jan 2020
All companies incorporated on 22 January 2020 · in Jan 2020.
09
Reminders for ONCOTECHNOLOGIES LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.